当前位置：
X-MOL 学术
›
Signal Transduct. Target Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs.
Signal Transduction and Targeted Therapy ( IF 40.8 ) Pub Date : 2021-08-23 , DOI: 10.1038/s41392-021-00722-0 Zhihui Zhang 1, 2 , Nan Sun 1, 2 , Jie He 1, 2
中文翻译：
切除的食管鳞状细胞癌的辅助免疫治疗：非 pCR 的福音。
更新日期：2021-08-23
Signal Transduction and Targeted Therapy ( IF 40.8 ) Pub Date : 2021-08-23 , DOI: 10.1038/s41392-021-00722-0 Zhihui Zhang 1, 2 , Nan Sun 1, 2 , Jie He 1, 2
Affiliation
中文翻译：
切除的食管鳞状细胞癌的辅助免疫治疗：非 pCR 的福音。
京公网安备 11010802027423号